The U.S. Food and Drug Administration has granted approval for application number ANDA078070, submitted by Pharmobedient.
The approval covers two oral tablet products of valacyclovir hydrochloride, identified as product numbers 001 and 002. Product 001 is a 500 mg equivalent tablet, and product 002 is a 1 g equivalent tablet.
Both products are listed with a marketing status of “Discontinued.” The submission was an original (ORIG) filing, received approval status (AP) on May 24, 2010.
Regulatorische Updates24. Aug. 2026•1 Min. Lesezeit
FDA Approves ANDA078070 for Valacyclovir Hydrochloride Tablets by Pharmobedient
The FDA approved application ANDA078070 submitted by Pharmobedient for oral valacyclovir hydrochloride tablets (500 mg and 1 g equivalents). Both products are listed as discontinued.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen